Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases (Q61453872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

Ernestine Nkwengoua Tchouboun Zondegoumba

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

Francisco J. B. Mendonça-Junior

20 April 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Marcus Tullius Scotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Luciana Scotti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

3

Anuraj Nayarisseri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Alex France M Monteiro

1

object named as

Alex France M Monteiro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Jéssika De O Viana

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

language of work or name

English

0 references

publication date

30 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

Oxidative Medicine and Cellular Longevity

20 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

7912765

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

20 April 2020

copyright license

start time

30 December 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

12 December 2020

Nomenclature and classification of purinoceptors.

1 reference

12 December 2020

Identification of two distinct synucleins from human brain

1 reference

12 December 2020

The pathogenesis of senile plaques

1 reference

12 December 2020

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

12 December 2020

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

1 reference

12 December 2020

Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat.

1 reference

12 December 2020

1 reference

12 December 2020

Monoamine oxidase: from genes to behavior

1 reference

12 December 2020

Regulation of ligand-gated ion channels by protein phosphorylation

1 reference

12 December 2020

Synucleins in synaptic plasticity and neurodegenerative disorders

1 reference

12 December 2020

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors

1 reference

12 December 2020

The Protein Data Bank

1 reference

12 December 2020

Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease

1 reference

12 December 2020

Adenosine A2A receptor facilitation of synaptic transmission in the CA1 area of the rat hippocampus requires protein kinase C but not protein kinase A activation

1 reference

12 December 2020

Regulation of AMPA receptors by phosphorylation

1 reference

12 December 2020

Catechol-O-methyltransferase decreases levodopa toxicity in vitro

1 reference

12 December 2020

Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.

1 reference

12 December 2020

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

1 reference

12 December 2020

Partial dopamine agonists in the treatment of psychosis

1 reference

12 December 2020

Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia

1 reference

12 December 2020

Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus

1 reference

12 December 2020

Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis

1 reference

12 December 2020

alpha- and beta-secretase: profound changes in Alzheimer's disease.

1 reference

12 December 2020

Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease

1 reference

12 December 2020

SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold

1 reference

12 December 2020

Systematic review of incidence studies of Parkinson's disease

1 reference

12 December 2020

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

1 reference

12 December 2020

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

1 reference

12 December 2020

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

1 reference

12 December 2020

A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD

1 reference

12 December 2020

Neurodegenerative diseases and oxidative stress

1 reference

12 December 2020

A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods

1 reference

12 December 2020

The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress

1 reference

12 December 2020

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

12 December 2020

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

12 December 2020

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

1 reference

12 December 2020

Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain

1 reference

12 December 2020

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

1 reference

12 December 2020

1 reference

12 December 2020

ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia.

1 reference

12 December 2020

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

1 reference

12 December 2020

IK682, a tight binding inhibitor of TACE

1 reference

12 December 2020

Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin

1 reference

12 December 2020

Targeting adenosine A2A receptors in Parkinson's disease

1 reference

12 December 2020

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

1 reference

12 December 2020

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

1 reference

12 December 2020

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease

1 reference

12 December 2020

Monoamine oxidase-B inhibition in the treatment of Parkinson's disease

1 reference

12 December 2020

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice

1 reference

12 December 2020

Probing the basis of domain-dependent inhibition using novel ketone inhibitors of Angiotensin-converting enzyme

1 reference

12 December 2020

Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence

1 reference

12 December 2020

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease

1 reference

12 December 2020

Adenosine A2A receptors and Parkinson's disease.

1 reference

12 December 2020

Current strategies in the treatment of Parkinson's disease and a personalized approach to management

1 reference

12 December 2020

Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients

1 reference

12 December 2020

Parkinson's Disease: Genetics and Pathogenesis

1 reference

12 December 2020

Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties.

1 reference

12 December 2020

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

1 reference

12 December 2020

GSK3 and Alzheimer's Disease: Facts and Fiction….

1 reference

12 December 2020

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

1 reference

12 December 2020

Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

1 reference

12 December 2020

Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor

1 reference

12 December 2020

Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene

1 reference

12 December 2020

The effect of genistein on the content and activity of α- and β-secretase and protein kinase C in Aβ-injured hippocampal neurons

1 reference

12 December 2020

Current and future treatments for Alzheimer's disease

1 reference

12 December 2020

Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?

1 reference

12 December 2020

Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease

1 reference

12 December 2020

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release

1 reference

12 December 2020

Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued

1 reference

12 December 2020

The prevalence of Parkinson's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models.

1 reference

12 December 2020

Evidence revealing deregulation of the KLF11-MAO A pathway in association with chronic stress and depressive disorders

1 reference

12 December 2020

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

12 December 2020

Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases

1 reference

12 December 2020

Flavonoid-based therapies in the early management of neurodegenerative diseases

1 reference

12 December 2020

BACE1 inhibitor drugs in clinical trials for Alzheimer's disease

1 reference

12 December 2020

The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice

1 reference

12 December 2020

A long-term study of istradefylline safety and efficacy in patients with Parkinson disease.

1 reference

12 December 2020

1 reference

12 December 2020

Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol.

1 reference

12 December 2020

Cancer therapy with phytochemicals: evidence from clinical studies

1 reference

12 December 2020

Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases

1 reference

12 December 2020

Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease

1 reference

12 December 2020

Molecular docking and structure-based drug design strategies

1 reference

12 December 2020

New treatments for levodopa-induced motor complications

1 reference

12 December 2020

Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.

1 reference

12 December 2020

Protective Mechanisms of Flavonoids in Parkinson's Disease

1 reference

12 December 2020

GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats

1 reference

12 December 2020

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

1 reference

12 December 2020

The prediagnostic phase of Parkinson's disease

1 reference

12 December 2020

Natural Xanthones from Garcinia mangostana with Multifunctional Activities for the Therapy of Alzheimer's Disease.

1 reference

12 December 2020

Phytochemicals as future drugs for Parkinson's disease: a comprehensive review.

1 reference

12 December 2020

Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors.

1 reference

12 December 2020

Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models

1 reference

12 December 2020

The clinical symptoms of Parkinson's disease

1 reference

12 December 2020

Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology

1 reference

12 December 2020

Interaction of Isoflurane, Tumor Necrosis Factor-α and β-Amyloid on Long-term Potentiation in Rat Hippocampal Slices

1 reference

12 December 2020

Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.

1 reference

12 December 2020

GSK3β 5'-flanking DNA Methylation and Expression in Alzheimer's Disease Patients.

1 reference

12 December 2020

Personalized genetics of the cholinergic blockade of neuroinflammation.

1 reference

12 December 2020

Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease

1 reference

12 December 2020

Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin.

1 reference

12 December 2020

Tumor necrosis factor α Inhibition for Alzheimer's Disease

1 reference

12 December 2020

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.

1 reference

12 December 2020

Deciphering microglial diversity in Alzheimer's disease

1 reference

12 December 2020

Integrated molecular landscape of Parkinson's disease

1 reference

12 December 2020

Computational Chemistry Study of Natural Alkaloids and Homemade Databank to Predict Inhibitory Potential Against Key Enzymes in Neurodegenerative Diseases.

1 reference

12 December 2020

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer's Disease Pathology.

1 reference

12 December 2020

Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease

1 reference

12 December 2020

Computer-aided drug design applied to Parkinson targets

1 reference

12 December 2020

Fraxinus: A Plant with Versatile Pharmacological and Biological Activities.

1 reference

12 December 2020

Specks of insight into Alzheimer's disease.

1 reference

12 December 2020

Factors Influencing the Potency of Alzheimer Inhibitors: Computational and Docking Studies

1 reference

12 December 2020

Melatonin ameliorates Aβ42 -induced alteration of βAPP-processing secretases via the melatonin receptor through the Pin1/GSK3β/NF-κB pathway in SH-SY5Y cells.

1 reference

12 December 2020

Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.

1 reference

12 December 2020

Alzheimer disease: BACE1 inhibitors block new Aβ plaque formation

1 reference

12 December 2020

BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions

1 reference

12 December 2020

A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease.

1 reference

12 December 2020

The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling.

1 reference

12 December 2020

Docking of Natural Products against Neurodegenerative Diseases: General Concepts.

1 reference

12 December 2020

BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer's disease.

1 reference

12 December 2020

Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies

1 reference

12 December 2020

Identifiers

DOI

10.1155/2018/7912765

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30693065%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

PubMed publication ID

30693065

1 reference